Synthesis and characterization of N-coumaroyltyramine as a potent phytochemical which arrests human transformed cells via inhibiting protein tyrosine kinases

Biochemical and Biophysical Research Communications

Volumn 292, Issue 4, 2002, Pages 1104-1110

  Park, Jae B ^b   Schoene, Norberta ^c  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

^b BELTSVILLE HUMAN NUTRITION RESEARCH CENTER   (United States)

^c NONE

Author keywords

Antiproliferation activity; Cell cycle; Epidermal growth factor receptor (EGFR); N coumaroyltyramine; Phytochemicals; Tyrosine kinase inhibitor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; N COUMAROYLTYRAMINE; PROTEIN TYROSINE KINASE; TYRAMINE; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE S PHASE; CELL GROWTH; CELL TRANSFORMATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENCY; DRUG PURIFICATION; DRUG SYNTHESIS; ENZYME INHIBITION; GROWTH INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PHYTOCHEMISTRY; PRIORITY JOURNAL; ULTRAVIOLET RADIATION;

EID: 0036290229     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2002.6752     Document Type: Article

References (39)

1. A pathogen-responsive gene of parsley encodes tyrosine decarboxylase
2. Cloning and characterization of a hydroxycin-namoyl-CoA:tyramine N-(hydroxycinnamoyl) transferase induced in response to UV-C and wounding from Capsicum annuum
3. Phenolic components of the primary cell wall. Feruloylated disaccharides of D-galactose and L-arabinose from spinach polysaccharide
4. Reduction of light-induced anthocyanin accumulation in inoculated sorghum mesocotyls. Implications for a compensatory role in the defense response
5. Cloning and expression of a potato cDNA encoding hydroxycinnamoyl-CoA:tyramine N-(hydroxycinnamoyl)transferase
6. Molecular cloning, induction and taxonomic distribution of caffeoyl-CoA 3-O-methyltransferase, an enzyme involved in disease resistance
7. Analysis and pharmacotoxicity of feruloyl-tyramine as a new constituent and p-coumaroyltyramine in Cannabis sativa L
8. Additional bioactive compounds and trilobacin, a novel highly cytotoxic acetogenin, from the bark of Asimina triloba
9. Aristolochic acids, aristolactam alkaloids and amides from Aristolochia kankauensis
10. Bioactive constitutents from the stems of Annona montana
11. Flavonoids. A class of natural products of high pharmacological potency
12. Flavonoids: Biochemical effects and therapeutic applications
13. Coupling reagents and activation
14. Alloxan cytotoxicity in vitro: Microscope photometric analyses of trypan blue uptake by pancreatic islet cells in suspension
15. Test for chemotherapeutic sensitivity of cerebral gliomas: Use of colorimetric MTT assay
16. + and cell shrinkage
17. Chemopreventive agent resveratrol, a natural product derived from grapes, reversibly inhibits progression through S and G2 phases of the cell cycle in U937 cells
18. The EGF receptor family as targets for cancer therapy
19. Growth factors and their receptors: New targets for prostate cancer therapy
20. On receptor inhibitors and chemotherapy
21. Anti-cancer drug discovery and development in Brazil: Targeted plant collection as a rational strategy to acquire candidate anti-cancer compounds
22. Studies leading to the identification of ZD1839 (Iressa): An orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer
23. Synergy of the proteinfarnesyltrans-ferase inhibitor SCH66336 and cisplatin in human cancer cell lines
24. Flavonoids are potential inhibitors of glucose uptake in U937 cells
25. Intracellular accumulation of ascorbic acid is inhibited by flavonoids via blocking both dehydroascorbic acid and ascorbic acid uptake in the transformed cells
26. Inhibition of glucose and dehydroascorbic acid uptake by resveratrol in human transformed myeolocytic cells
27. Cell cycle checkpoints: Preventing identity crisis
28. A matter of life and cell death
29. A century of homeosis, a decade of homeoboxes
30. SU6656, a selective Src family kinase inhibitor, used to probe growth factor signaling
31. Chronic myelogenous leukemia
32. Chronic myelogenous leukaemia - New therapeutic principles
33. Chronic myeloid leukemia: Current treatment options
34. Limited proteolysis of filamin is catalyzed by caspase-3 in U937 and Jurkat cells
35. Comparative study of the cytotoxicity and apoptosis-inducing potential of commonly occurring oxysterols